13
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Recurrent astrocytic tumours - a study of p53 immunoreactivity and malignant progression

, , &
Pages 335-342 | Published online: 06 Jul 2009

  • Afra D, Muller W, Benoist G, Shroeder R. Supratentorial recurrences of gliomas: Results of reoperation on astrocytomas and oligodendrogliomas. Acta Neurochir (Wien) 1978;43:217-27.
  • Cavenee WK, Fumari FB, Nagane M, Huang H-JS, Newcomb EW, Bigner DD, Weller M, Berens ME, Plate KH, Israel MA, Noble MD, Kleihues P. Diffusely infiltrating astrocytomas. In: Kleihues P, Cavenee WK, eds, Pathology and genetics of tumours of the nervous system: WHO classification of tumours. International Agency for Research on Cancer, Lyon, 2000:10-21.
  • von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Weis tier OD, Seizinger BR. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 1992;52:2987-90.
  • Sidransky D, Mikkelsen T, Schweichheimer K, Rosenblum M, Cavenee WK, Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992;355:846-8.
  • Louis DN. The p53 gene and protein in human brain tumours. J Neumpathol Exp Neural 1994;53:11-21.
  • Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK, Sinha S. Loss of heterozygosity of a locus on 17pl3.3 independent of p53, is associated with higher grades of astrocytic tumours. Oncogens 1997;15:871-4.
  • van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG. p53 mutation, expression and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J Natl Cancer Inst 1994;86:1011-17.
  • Reifenberger J, Ring GU, Gies U, Cobbers L, Oberstrass J, An HX, Niederacher D, Wechsler W, Reifenberger G. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neumpathol Exp Neural 1996;55:822-31.
  • Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N,Yonekawa Y, Kleihues P, Ohgaki H. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res 1997;3:523-30.
  • Krouwer HG, Davis RL, Silver P, Prados M. Gemistocytic astrocytomc: a reappraisal. J Neurosurg 1991;74:399-406.
  • Watanabe K, Tachibana O, Yonekawa, Kleihues P, Ohgaki H. Role of gemistocytes in a astrocytoma progression. Lab Invest 1997;76(277-84.)
  • Mercer WE, Shields MT, Amin M. Negative growth regulation in a glioblastoma tumour line that conditionally expresses human wild type p53. Proc NadAcad Sc USA 1990;87:6166-70.
  • Van Meir EG, Roemer K, Diserens AC, Kikuchi T, Rempel SA, Haas M, Huang HJ, Friedmann T, de Tribolet N, Cavenee WK. Single cell monitoring of growth arrest and morphological changes induced by transfer of wild type p53 alleles to glioblastoma cells. Proc NadAcadSd USA 1995;92:1008-12.
  • Fulci G, Ishii N,Van Meir EG. p53 and brain tumours: from gene mutations to gene therapy. Brain Pathol 1998;8:599-613.
  • Ohgaki H, Eibl RH, Schwab M, Reichel MB, Mariani L, Gehring M, Peterson I, HoIl T, Wiestler OD, Kleihues P. Mutations of the p53 tumour suppressor gene in neoplasms of the human nervous system. MoI Carcinog 1993;8:74-80.
  • Patt S, Gries H, Giraldo M, Cervos NJ, Martin H, Janisch W, Brockmoller J. p53 gene mutations in human astrocytic brain tumours including pilocytic astrocytomas. Hum Pathol 1990;27:586-9.
  • von Deimling A, von Ammon K, Schoenfield D, Weistier OD, Seizinger BR, Louis DN. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993;3:19-26.
  • Lang FF, Miller DC, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumours. J Neurosurg 1994;8:427-434.
  • Newcomb EW, Madonia WJ, Pisharody 5, Lang FF, Koslow N, Miller DC. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 1993;3:229-35.
  • Sarkar C, Rathore A, Chattopadhya P, Mahapatra AK, Sinha S. Role of 17p13.3 chromosomal region in determining p53 protein immunopositivity in human astrocytic tumours. Pothology_2000;32:84-8.
  • Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues P, Ohgaki H. p53 and PTEN mutations in gennistocytic astrocytomas. Acta Neuropathol (Berl) 1998;95: 559-60.
  • luzzolino P, Ghimenton C, Nicolato A, Giorguitti F, Fina P, Doglioni C, Barbareschi M. p53 protein expression in low grade astrocytoma: a study with long term follow up. Br J Cancer 1994;69:586-91.
  • Kraus JA, Bolln C9WoIfHK, Neumann J, Kindermann D, Fimmers R, Forster F, Baumann A, Schiegel U. Tp53 alterations and clinical outcome in low grade astrocytomas. Genes Chromosom Cancer 1994;10: 143-9.
  • Rasheed BY, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH. Alterationsof the TP53 gene in human gliomas. Cancer Res 1994;54:1324-30.
  • Al-Sarraj S, Bridges LR. p53 immunoieactivity in astrocytomas and its relationship to survival. Br J Neurosurg 1995;9:143-9.
  • Hayashi Y, Yamashita J, Yamaguchi K. Timing and role of p53 gene mutation in the recurrence of glioma. Biochem Biophys Res 1991;180:1145-50.
  • Tynninen O, Paetau A, von Boguslawski K, Jaaskelinen J, Aronen HJ, Paavonen T. p53 expression in tissue microarray of primary and recurrent gliomas. Brain Pathol 2000;10:575 (abstract).
  • Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996;6:217-24.
  • Rasheed BKA, Wiltshire RN, Bigner SN, Bigner DD. Molecular pathogenesis of malignant gliomas. Curr Opin Oncol 1999;11:162-7.
  • Laws ER Jr, Taylor VIP, Clifton MB, Okazati H. Neurosurgical management of low grade astrocytoma of the cerebral hemispheres. J Neurosurg 1984;61: 665-73.
  • Soffietti R, Chio A, Giordano MT Vasario E, Schiffer D. Prognostic factors in well differentiated cerebral astrocytomas in the adult. Neurosurgery 1989;24: 686-92.
  • Vertosik PT, Selker RG, Arena VC. Survival of patients with well differentiated astrocytomas diagnosed in the era of computed tomography. Neurosurgery 1991 ;28: 496-501.
  • Recht LD, Lew R, Smith TW. Suspected low grade glioma: Is deferring treatment safe? Ann Neural 1992; 31:431-6.
  • Winger MJ, Macdonald DR, Cairncross JO. Supratentorial anaplastic gliomas in adults. The prognostic important of extent of resection and prior low grade glioma. J Neurosurg 1989;71:787-793.
  • Tandon PN, Mahapatra AK, Sarkar C, Khosla A. Recurrence of supratentorial gliomas. Neural India 1997;45:141-49.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.